EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays

Joseph P Nkolola, Jinyan Liu, Ai-Ris Y Collier, Catherine Jacob-Dolan, Yasmeen Senussi, Ella Borberg, Zoe Swank, David R Walt, Dan H Barouch iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Joseph P Nkolola und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, Center for Virology and Vaccine Research, Boston, Massachusetts. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is typically measured by nucleocapsid serology assays. In this study, we show that the Simoa serology assay and T-cell intracellular cytokine staining assay are more sensitive than the clinical Elecsys assay for detection of nucleocapsid-specific immune responses. These data suggest that the prevalence of prior SARS-CoV-2 infection in the population may be higher than currently appreciated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansMiddle AgedAntibodies, ViralFemaleMaleNucleocapsidAdultCOVID-19 Serological TestingSensitivity and SpecificityAgedCoronavirus Nucleocapsid ProteinsT-LymphocytesCytokines

Stichwörter der Autor:innen

SARS-CoV-2immunityinfectionnucleocapsidserology

Substanzen

Antibodies, ViralCoronavirus Nucleocapsid ProteinsCytokines

Autor:innen und Institutionen

  • Beth Israel Deaconess Medical Center, Center for Virology and Vaccine Research, Boston, Massachusetts.
  • Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.

ORCID-Profile: Dan H Barouch

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • Massachusetts Consortium for Pathogen Readiness
  • National Institutes of Health

Zitieren

APA

Nkolola, J. P., Liu, J., Collier, A. Y., Jacob-Dolan, C., Senussi, Y., Borberg, E., Swank, Z., Walt, D. R., & Barouch, D. H. (2024). High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae174

Vancouver

Nkolola JP, Liu J, Collier AY, Jacob-Dolan C, Senussi Y, Borberg E, et al. High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae174

BibTeX
@article{Nkolola2024,
  author = {Nkolola, Joseph P and Liu, Jinyan and Collier, Ai-Ris Y and Jacob-Dolan, Catherine and Senussi, Yasmeen and Borberg, Ella and Swank, Zoe and Walt, David R and Barouch, Dan H},
  title = {High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae174}
}
Kostenlos starten →